BRIEF-Ligand enters into worldwide Omniab platform license agreement with Surface Oncology By: Reuters: Company News June 01, 2017 at 09:24 AM EDT * Ligand enters into worldwide Omniab® platform license agreement with Surface Oncology Read More >> Related Stocks: Ligand Pharm